Our study also determined the tumor-suppressing function of SNHG1 knockdown at molecular levels, corresponding to reductions in MMP-2, MMP-9, Bcl-2, and N-cadherin and elevations in Bax and E-cadherin. The gene discussed is MMP9; the disease is neoplasm.